EXHIBIT 99.2

WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2006		2005		2006			2005
Revenue	$	66,645	$	45,094	$	173,308		$	119,834
Costs and expenses:
Cost of operations		26,945		18,020		77,371			51,531
Sales and marketing		20,472		13,534		52,941			36,663
General and administrative		13,476		6,582		37,931			21,787
Depreciation and amortization		5,085		2,733		12,627			7,985
Interest income		1,221		10		4,137			10
Income (loss) before income tax provision		1,888		4,235		(3,425	)		1,878
Income tax provision		896		112		908			264
Net income (loss)	$	992	$	4,123	$	(4,333	)	$	1,614
Net income (loss) per common share:
Basic	$	0.02	$	0.09	$	(0.08	)	$	0.03
Diluted	$	0.02	$	0.09	$	(0.08	)	$	0.03
Weighted-average shares outstanding used in computing basic and diluted net income (loss) per common share:
Basic		56,059		48,273		56,056			48,158
Diluted		58,122		48,302		56,056			48,167

WEBMD HEALTH CORP.
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2006			2005			2006			2005
Revenue
Online Services:
Advertising and sponsorship	$	43,534		$	28,054		$	112,513		$	77,497
Licensing		14,569			9,053			38,315			23,097
Content syndication and other		843			2,124			2,815			6,697
Total Online Services		58,946			39,231			153,643			107,291
Publishing and Other Services		7,699			5,863			19,665			12,543
	$	66,645		$	45,094		$	173,308		$	119,834
Earnings before interest, taxes, depreciation, amortization and other non-cash items (“Adjusted EBITDA”)
Online Services	$	12,727		$	7,795		$	29,594		$	15,588
Publishing and Other Services		1,906			1,282			1,165			367
		14,633			9,077			30,759			15,955
Adjusted EBITDA per diluted common share (a)	$	0.25		$	0.19		$	0.55		$	0.33
Interest, taxes, depreciation, amortization and other non-cash items (b)
Interest income		1,221			10			4,137			10
Depreciation and amortization		(5,085	)		(2,733	)		(12,627	)		(7,985	)
Non-cash advertising		(1,660	)		(1,707	)		(4,454	)		(5,121	)
Non-cash stock-based compensation		(7,221	)		(412	)		(21,240	)		(981	)
Income tax provision		(896	)		(112	)		(908	)		(264	)
Net income (loss)	$	992		$	4,123		$	(4,333	)	$	1,614
Net income (loss) per common share:
Basic	$	0.02		$	0.09		$	(0.08	)	$	0.03
Diluted	$	0.02		$	0.09		$	(0.08	)	$	0.03
Weighted-average shares outstanding used in computing basic and diluted net income (loss) per common share:
Basic		56,059			48,273			56,056			48,158
Diluted		58,122			48,302			56,056			48,167

(a)	Three and nine months ended September 30, 2006 Adjusted EBITDA per diluted common share is calculated based on 58,122 and 57,977 diluted shares, respectively. Three and nine months ended September 30, 2005 Adjusted EBITDA per diluted common share is calculated based on 48,302 and 48,167 diluted shares, respectively.
(b)	Reconciliation of Adjusted EBITDA to net income (loss) (see Annex A — Explanation of Non-GAAP Financial Measures).

WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)

	September 30,		December 31,
	2006		2005
ASSETS
Current assets:
Cash and cash equivalents	$	45,164	$	75,704
Short-term investments		39,922		78,073
Accounts receivable, net		71,009		57,245
Current portion of prepaid advertising		4,725		7,424
Other current assets		8,578		3,977
Total current assets		169,398		222,423
Property and equipment, net		37,449		21,014
Prepaid advertising		10,350		12,104
Goodwill		174,311		100,669
Intangible assets, net		38,900		20,503
Other assets		257		176
	$	430,665	$	376,889
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accrued expenses	$	24,912	$	30,400
Deferred revenue		69,380		36,495
Due to Emdeon		11,866		3,672
Total current liabilities		106,158		70,567
Other long-term liabilities		7,907		7,010
Stockholders’ equity		316,600		299,312
	$	430,665	$	376,889

WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

	Nine Months Ended
	September 30,
	2006			2005
Cash flows from operating activities:
Net income (loss)	$	(4,333	)	$	1,614
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization		12,627			7,985
Non-cash advertising		4,454			5,121
Non-cash stock-based compensation		21,240			981
Changes in operating assets and liabilities:
Accounts receivable		(7,661	)		(1,490	)
Other assets		(5,111	)		1,185
Accrued expenses and other long-term liabilities		(544	)		2,798
Due to Emdeon		8,213			—
Deferred revenue		14,517			778
Net cash provided by operating activities		43,402			18,972
Cash flows from investing activities:
Proceeds from maturities and sales of available-for-sale securities		261,000			—
Purchases of available-for-sale securities		(222,000	)		—
Purchases of property and equipment		(17,500	)		(15,587	)
Cash paid in business combinations, net of cash acquired		(96,091	)		(30,819	)
Net cash used in investing activities		(74,591	)		(46,406	)
Cash flows from financing activities:
Proceeds from issuance of common stock		649			—
Net cash transfers from Emdeon		—			65,090
Net cash provided by financing activities		649			65,090
Net increase (decrease) in cash and cash equivalents		(30,540	)		37,656
Cash and cash equivalents at beginning of period		75,704			3,456
Cash and cash equivalents at end of period	$	45,164		$	41,112